Redeye: Calliditas Therapeutics: Scores a record deal in China
In this research update, we dig deeper into the Greater China deal and provide you with a brief update on the competitive landscape within IgA Nephropathy. Read more and download the analysis: http://bit.ly/2Fdu46W Start following companies at Redeye to recieve the latest equity research within Life Science and Technology. This is a press release from